ARCADIS NV (ARCAD.AS) Stock Fundamental Analysis

AMS:ARCAD • NL0006237562

35.76 EUR
-1.62 (-4.33%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall ARCAD gets a fundamental rating of 4 out of 10. We evaluated ARCAD against 34 industry peers in the Professional Services industry. While ARCAD has a great profitability rating, there are some minor concerns on its financial health. ARCAD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ARCAD had positive earnings in the past year.
  • In the past year ARCAD had a positive cash flow from operations.
  • ARCAD had positive earnings in each of the past 5 years.
  • ARCAD had a positive operating cash flow in each of the past 5 years.
ARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

  • ARCAD's Return On Assets of 6.17% is fine compared to the rest of the industry. ARCAD outperforms 76.47% of its industry peers.
  • ARCAD has a better Return On Equity (22.00%) than 70.59% of its industry peers.
  • The Return On Invested Capital of ARCAD (10.90%) is better than 73.53% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ARCAD is in line with the industry average of 11.61%.
  • The last Return On Invested Capital (10.90%) for ARCAD is above the 3 year average (9.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.17%
ROE 22%
ROIC 10.91%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ARCAD.AS Yearly ROA, ROE, ROICARCAD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • ARCAD has a Profit Margin of 6.17%. This is in the better half of the industry: ARCAD outperforms 70.59% of its industry peers.
  • ARCAD's Profit Margin has improved in the last couple of years.
  • ARCAD has a better Operating Margin (9.64%) than 70.59% of its industry peers.
  • ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.64%
PM (TTM) 6.17%
GM N/A
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
ARCAD.AS Yearly Profit, Operating, Gross MarginsARCAD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ARCAD is still creating some value.
  • Compared to 1 year ago, ARCAD has less shares outstanding
  • ARCAD has more shares outstanding than it did 5 years ago.
  • ARCAD has a better debt/assets ratio than last year.
ARCAD.AS Yearly Shares OutstandingARCAD.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARCAD.AS Yearly Total Debt VS Total AssetsARCAD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.52 indicates that ARCAD is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.52, ARCAD is in line with its industry, outperforming 47.06% of the companies in the same industry.
  • The Debt to FCF ratio of ARCAD is 5.46, which is a neutral value as it means it would take ARCAD, 5.46 years of fcf income to pay off all of its debts.
  • ARCAD has a Debt to FCF ratio of 5.46. This is comparable to the rest of the industry: ARCAD outperforms 52.94% of its industry peers.
  • ARCAD has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of ARCAD (1.12) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 5.46
Altman-Z 2.52
ROIC/WACC1.72
WACC6.35%
ARCAD.AS Yearly LT Debt VS Equity VS FCFARCAD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • ARCAD has a Current Ratio of 1.27. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
  • ARCAD's Current ratio of 1.27 is fine compared to the rest of the industry. ARCAD outperforms 70.59% of its industry peers.
  • ARCAD has a Quick Ratio of 1.27. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.27, ARCAD is doing good in the industry, outperforming 73.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
ARCAD.AS Yearly Current Assets VS Current LiabilitesARCAD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.7%

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.28% on average over the next years.
  • ARCAD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.52% yearly.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

ARCAD.AS Yearly Revenue VS EstimatesARCAD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
ARCAD.AS Yearly EPS VS EstimatesARCAD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.22 indicates a rather expensive valuation of ARCAD.
  • The rest of the industry has a similar Price/Earnings ratio as ARCAD.
  • ARCAD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 20.81, the valuation of ARCAD can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ARCAD indicates a slightly more expensive valuation: ARCAD is more expensive than 67.65% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, ARCAD is valued a bit cheaper.
Industry RankSector Rank
PE 23.22
Fwd PE 20.81
ARCAD.AS Price Earnings VS Forward Price EarningsARCAD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARCAD indicates a somewhat cheap valuation: ARCAD is cheaper than 67.65% of the companies listed in the same industry.
  • ARCAD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ARCAD is cheaper than 64.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.83
EV/EBITDA 8.53
ARCAD.AS Per share dataARCAD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ARCAD does not grow enough to justify the current Price/Earnings ratio.
  • ARCAD has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)2.39
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • ARCAD has a Yearly Dividend Yield of 2.57%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.51, ARCAD has a dividend in line with its industry peers.
  • ARCAD's Dividend Yield is a higher than the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.57%

5.2 History

  • The dividend of ARCAD is nicely growing with an annual growth rate of 31.53%!
Dividend Growth(5Y)31.53%
Div Incr Years6
Div Non Decr Years6
ARCAD.AS Yearly Dividends per shareARCAD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ARCAD pays out 37.39% of its income as dividend. This is a sustainable payout ratio.
DP37.39%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
ARCAD.AS Yearly Income VS Free CF VS DividendARCAD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
ARCAD.AS Dividend Payout.ARCAD.AS Dividend Payout, showing the Payout Ratio.ARCAD.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ARCADIS NV

AMS:ARCAD (2/12/2026, 7:00:00 PM)

35.76

-1.62 (-4.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners58.87%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap3.23B
Revenue(TTM)1.89B
Net Income(TTM)238.00M
Analysts80
Price Target53.35 (49.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.57%
Yearly Dividend0.85
Dividend Growth(5Y)31.53%
DP37.39%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25.48%
Min EPS beat(2)-36.09%
Max EPS beat(2)-14.86%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-30.78%
Min Revenue beat(2)-35.5%
Max Revenue beat(2)-26.05%
Revenue beat(4)0
Avg Revenue beat(4)-17.6%
Min Revenue beat(4)-35.5%
Max Revenue beat(4)-4.39%
Revenue beat(8)0
Avg Revenue beat(8)-15.75%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.98%
PT rev (3m)-14.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-2.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE 23.22
Fwd PE 20.81
P/S 0.84
P/FCF 12.83
P/OCF 11.19
P/B 2.99
P/tB N/A
EV/EBITDA 8.53
EPS(TTM)1.54
EY4.31%
EPS(NY)1.72
Fwd EY4.81%
FCF(TTM)2.79
FCFY7.79%
OCF(TTM)3.2
OCFY8.94%
SpS42.66
BVpS11.96
TBVpS-4.58
PEG (NY)2.39
PEG (5Y)N/A
Graham Number20.36
Profitability
Industry RankSector Rank
ROA 6.17%
ROE 22%
ROCE 15.97%
ROIC 10.91%
ROICexc 12.52%
ROICexgc 42.24%
OM 9.64%
PM (TTM) 6.17%
GM N/A
FCFM 6.53%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ROICexc(3y)11.24%
ROICexc(5y)11.87%
ROICexgc(3y)46.91%
ROICexgc(5y)45.96%
ROCE(3y)13.66%
ROCE(5y)13.67%
ROICexgc growth 3Y8.93%
ROICexgc growth 5Y-10.74%
ROICexc growth 3Y2.55%
ROICexc growth 5Y6.48%
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 5.46
Debt/EBITDA 2.4
Cap/Depr 27.21%
Cap/Sales 0.96%
Interest Coverage 8.65
Cash Conversion 56.89%
Profit Quality 105.88%
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 2.52
F-Score7
WACC6.35%
ROIC/WACC1.72
Cap/Depr(3y)29.56%
Cap/Depr(5y)27.6%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.19%
Profit Quality(3y)159.52%
Profit Quality(5y)558.67%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.7%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y14.27%
EBIT growth 3Y20.69%
EBIT growth 5Y17.72%
EBIT Next Year33%
EBIT Next 3Y16.66%
EBIT Next 5Y11.52%
FCF growth 1Y103.03%
FCF growth 3Y1.15%
FCF growth 5Y12.49%
OCF growth 1Y72.3%
OCF growth 3Y2.04%
OCF growth 5Y9.96%

ARCADIS NV / ARCAD.AS FAQ

Can you provide the ChartMill fundamental rating for ARCADIS NV?

ChartMill assigns a fundamental rating of 4 / 10 to ARCAD.AS.


What is the valuation status for ARCAD stock?

ChartMill assigns a valuation rating of 3 / 10 to ARCADIS NV (ARCAD.AS). This can be considered as Overvalued.


Can you provide the profitability details for ARCADIS NV?

ARCADIS NV (ARCAD.AS) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ARCADIS NV (ARCAD.AS) stock?

The Price/Earnings (PE) ratio for ARCADIS NV (ARCAD.AS) is 23.22 and the Price/Book (PB) ratio is 2.99.


What is the financial health of ARCADIS NV (ARCAD.AS) stock?

The financial health rating of ARCADIS NV (ARCAD.AS) is 5 / 10.